Update: AstraZeneca Receives Positive EMA Recommendation For Olaparib
- AstraZeneca announced Friday the EU recommendation for approval for Olaparib.
- I reiterate my bull thesis, as Astra continues to increase its growth prospects.
- As expected, the company continues to demonstrate its viability independent of Pfizer. The positive EU recommendation corroborates this position.